Emily Field analyst BARCLAYS

Currently out of the existing stock ratings of Emily Field, 27 are a BUY (57.45%), 13 are a HOLD (27.66%), 7 are a SELL (14.89%).

Emily Field

Work Performance Price Targets & Ratings Chart

Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 36.51% that have a potential upside of 4.62% achieved within 70 days.

Emily Field’s has documented 85 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVS, Novartis AG ADR at 02-Feb-2025.

Wall Street Analyst Emily Field

Analyst best performing recommendations are on GLPG (GALAPAGOS NV ADR).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 3/2/2021. The price target of $82.77 was fulfilled within 1 day with a profit of $1.59 (1.88%) receiving and performance score of 18.85.

Average potential price target upside

ARGX argenx NV ADR AZN AstraZeneca PLC ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR UCBJY UCB SA ADR SNY Sanofi ADR GRFS Grifols SA ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$1040

$243.08 (30.50%)

$750

16 days ago
(01-Oct-2025)

20/21 (95.24%)

$272.67 (35.53%)

190

Buy

$1070

$273.08 (34.27%)

$1065

29 days ago
(18-Sep-2025)

12/15 (80%)

$338.23 (46.22%)

155

Buy

$887

$90.08 (11.30%)

$607

1 months 15 days ago
(02-Sep-2025)

6/7 (85.71%)

$180.59 (25.56%)

242

Buy

$830

$33.08 (4.15%)

$805

2 months 13 days ago
(04-Aug-2025)

13/15 (86.67%)

$139.68 (20.23%)

220

Buy

$720

$-76.92 (-9.65%)

$720

3 months 16 days ago
(01-Jul-2025)

32/32 (100%)

$177.53 (32.73%)

158

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Emily Field?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?